Chineseinvestors.com INC (OTCMKTS:CIIX) Making Big Moves

Since its sudden rise in February 2017, Chineseinvestors.com INC (OTCMKTS:CIIX) has not exactly been the investors’ choice. Its recent agreements with Blockchain LLC and the announcements from its subsidiary ChineseHemoOil Inc has gathered enough attention to move the price from $0.5 to $1.25 within a month. Here we give you the details of the company and the announcements that caused the recent price reaction.First, take a look at the stock’s price movement below: CIIX Daily ChartBrief OverviewFor our readers who may not be very familiar with the firm, here is a brief overview of the companyChineseInvestors.COM, Inc was established in 1999 and became a public company in early 2011. The firm engages in real-time market commentary, analysis, and educational related services related to the various equity and globally positioned markets in Chinese language character sets (traditional and simplified), delivery of support and back of the house related services to our various partners, consultative services to smaller private companies considering their public company options, advertising and public company related support services (IR Lite), and other services which can potentially create value or partnership opportunities that blend efficiently with its existing skills and services.As an example of these other services, the Company is currently working with Medicine Man Denver in the creation of a new intellectual property and industry experience based corporate entity that will provide licensing and consulting services within the emerging Cannabis sector. The firm’s subscriber base is primarily based in US and Canada noting the services as described are generally delivered to US public and private companies as well as US residents and citizens.Recent DevelopmentsThe firm recently announced that its wholly owned subsidiary ChineseHempOil.com, Inc. launched its OptHemp product line on Amazon.com kicking off a multi-channel campaign geared to both the US and Chinese-American markets during the 9th annual Singles Day Celebration.This commences the e-commerce marketplace initiative that the Company set into motion in early June through a strategic partnership with Quiverr Collective ,a subsidiary of Advantage Solutions. Quiverr is a top 100, platinum level partner seller on Amazon Marketplace and has agreed to include the OptHemp product line in its limited catalog for resale through the Amazon Channel. As a wholly owned subsidiary of Advantage Solutions, Quiverr brings tremendous resources and knowledge and specified capabilities to drive sales on the Amazon channel using performance-based resale model. Advantage Solutions is a national sales and marketing agency that specializes in providing business solutions including headquarter sales services, analytics, insights and intelligence, retail services, marketing, digital technology and business process outsourcing. The OptHemp products launched on Amazon.com represent the Company's first use of Amazon for product sales.The Company also has plans to launch two new, first-of-their-kind products that will be available on Amazon.com before the Black Friday and Cyber Monday shopping extravaganzas. With two product lines launching on Amazon.com, the Company hopes to make the most of the upcoming holiday buying season positioning itself to earn generous revenues.ChineseInvestors.com, Inc. announces plans to spin off its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., and its wholly-owned subsidiary, ChineseHempOil.com, Inc., to be registered as a separate publically traded company allowing CIIX to focus on its new Cryptocurrency Division and its Core Financial Education Business.The Company's Board of Directors approved plans to spin off the Consumer Products Division in both the United States and China, which includes its hemp oil assets and its new wholesale alcohol distribution business, at the end of February 2018. The Company will take appropriate steps for the shares of the subsidiary's common stock to be listed for trading on the OTC:QB. The Company hopes to emulate the success it experienced in incubating Medicine Man Technologies, Inc as it transitioned from a private startup company to successful public company.CBD Biotechnology Co. Ltd. has recently acquired a Wholesale Alcohol License in Chinathereby expanding its Chinese consumer division to include distribution of "baijiu," the grain liquor known as the toast of choice for the Chinese. On November 7, 2017, CBD Biotechnology was issued Wholesale Alcohol License from the ShangHai Wine Monopoly Bureau effective October 24, 2107 for a three year term.CBD Biotechnology has also entered into a wholesale agreement with China GuiZhou HanTai Wine, Inc. to distribute its brand of baijiu, Yantai 1985, and has kicked off its sales and marketing plan by partnering with Jinri Toutiaoa popular Chinese mobile application just in time to launch for the Chinese New Year. Founded in 1979, China GuiZhou HanTai Wine, Inc.'s top-selling baijiu brand, Yantai 1985, is produced in the town of Maotai in China's Guizhou province. Moutai is renowned for having the purest water in China; therefore, spirits produced in Moutai have a distinct taste and pleasing aroma attributable to the use of local water in the production.Today's Headlines, the first broad news aggregator app in China, with content ranging from real-time news to music, movies, games, and shopping, is one of the most popular and fastest growing mobile apps in China with over 600 million registered users. Today's Headlines provides CBD Biotechnology a cost effective, convenient, and trustworthy platform to directly connect with millions of users to market Yantai 1985, the CBD Magic Hemp Series skincare line and other complimentary consumer product lines it may identify in the near future. Reports indicate that online sales of alcohol beverages in China will double by 2020 as more consumers look for product information online before buying. Through its relationship with China GuiZhou HanTai Wine, Inc. and Today's Headlines, CBD Biotechnology hopes to capitalize on this growing consumer trend to expand its brand awareness and achieve sustainable revenue growth.Company FinancialsA quick look at the firm’s statement of comprehensive income reveals that it has improved from the 61% reduction in revenue in 2016 to a 75% increase in 2017, a likely sign of recovery. However, net loss increased by a whopping 68% mainly as a result of the increase in selling, general and admin expenses.The firm is not very highly leveraged as the largest portion of its liabilities are account payables. It also acquired some long term investments which increased its asset base by just 3%.ConclusionCIIX has invested in the right technology, which is blockchain. It remains to be seen how this will pay off for its investors.We will be updating our subscribers as soon as we know more. For the latest updates on CIIX, sign up below!Disclosure: We have no position in CIIX and have not been compensated for this article.